ginsenoside rh2 has been researched along with betulinic acid in 2 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (betulinic acid) | Trials (betulinic acid) | Recent Studies (post-2010) (betulinic acid) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 1,025 | 1 | 676 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | betulinic acid (IC50) |
|---|---|---|---|
| Ubiquitin-like modifier activating enzyme 2 | Homo sapiens (human) | 11.2 | |
| SUMO1 activating enzyme subunit 1 | Homo sapiens (human) | 11.2 | |
| SUMO-conjugating enzyme UBC9 | Homo sapiens (human) | 11.2 | |
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 2 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 6.5 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 1.5 | |
| 5'-nucleotidase | Homo sapiens (human) | 7.28 | |
| Non-structural protein 1 | Dengue virus | 1.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, X; Guo, X; He, K; Jin, YH; Li, Q; Li, Y; Sun, C; Wang, X; Zhan, Z | 1 |
| Cai, N; Jin, X; Yang, Q; Zhang, Z | 1 |
2 other study(ies) available for ginsenoside rh2 and betulinic acid
| Article | Year |
|---|---|
Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Betulinic Acid; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Cytochromes c; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Flow Cytometry; Ginsenosides; HeLa Cells; Hep G2 Cells; Humans; Molecular Structure; Neoplasms; Pentacyclic Triterpenes; Poly(ADP-ribose) Polymerases; Protein Transport; RNA Interference; Triterpenes | 2011 |
A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment.
Topics: A549 Cells; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Betulinic Acid; Biphenyl Compounds; Cell Proliferation; Cisplatin; Ginsenosides; Humans; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Pentacyclic Triterpenes; Sesquiterpenes; Triterpenes; Xenograft Model Antitumor Assays | 2020 |